Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment

Phase

N/A

Condition

Breast Cancer

Cancer

Treatment

Activity tracker

Clinical Study ID

NCT05634395

IC 2021-08

Ages > 70
Female

Study Summary

GrannyFit is a prospective, national, multicenter, single-arm open-label study. It will include a total of 200 participants over the age of 70 years treated for de novo or recurrent (local or distant) BC. Participants will receive a Withing Steel activity tracker, which they will be asked to wear 24 h per day for 12 months. The principal assessments will be performed at baseline, at 6 months and at 12 months. The investigators will evaluate clinical (e.g. comorbidities), lifestyle, quality of life, fatigue, and physical activity parameters. All questionnaires will be completed on a REDCap form, via a secure internet link.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Women over 70 years of age,
With histologically confirmed invasive breast cancer,
Regardless of histological subtype (hormone receptor positive (HR+), negative (HR-),with or without HER2 overexpression, or triple negative)
Treated with local (surgery, radiotherapy) or systemic (hormone therapy,monotherapy, anti HER2, chemotherapy: patient is eligible for inclusion up to onemonth after initial diagnosis or recurrence (local or distant) of breast cancer,
PS ≤ 2,
Willing and available to invest in the project for the duration of the study,
Using a personal smartphone or personal tablet compatible with the "Withings HealthMate" app (iOS 10/android 5.0 and later) and with an internet connection,
Affiliated with a social security plan,
Having dated and signed an informed consent,
Able to read, write and understand French.

Exclusion

Exclusion Criteria:

Presence of disabling metastases,
Moderate to severe cognitive impairment,
Persons deprived of liberty or under guardianship,
Inability to undergo the medical follow-up of the trial for geographical, social orpsychological reasons,

Study Design

Activity tracker

February 17, 2023

May 19, 2026

Study Description

BACKGROUND: In metropolitan France in 2017, 58,968 new cases of breast cancer (BC) were estimated, of which 25,283 (46.7%) involved women older than 65 years. Older patients with cancer often present complex health needs, in particular because of the burden of comorbidities combined with the effects of aging, the cancer and its treatments. GrannyFit aims to use an activity tracker to identify and describe various digital profiles (physical activity, sleep) in women over 70 years of age treated de novo or recurrent (local or distant) BC.

METHODS: GrannyFit is a prospective, national, multicenter, single-arm open-label study. It will include a total of 200 participants over the age of 70 years treated for de novo or recurrent (local or distant) BC. Participants will receive a Withing Steel activity tracker, which they will be asked to wear 24 h per day for 12 months. The principal assessments will be performed at baseline, at 6 months and at 12 months. The investigators will evaluate clinical (e.g. comorbidities), lifestyle, quality of life, fatigue, and physical activity parameters. All questionnaires will be completed on a REDCap form, via a secure internet link.

DISCUSSION: GrannyFit will make it possible, through the use of an activity tracker, to visualize changes, over a one-year period, in the lifestyle of older BC patients. This study identify more precisely the unmets needs of this population and optimize their care through specific paths. This trial will also pave the way for interventional studies on physical activity and sleep interventions in this population.

Connect with a study center

Centre Léon Bérard
Lyon, 69008
France
Site Not Available
Institut Curie
Paris, 75005
France
Site Not Available
Institut GODINOT
Reims, 51100
France
Site Not Available
Institut Curie
Saint-Cloud, 92210
France
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.